C.Q. Pharmaceutical Holding Co., Ltd.

000950

CNE0000010K0

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 06:00:00 2024-05-12 pm EDT			5-day change	1st Jan Change
5.64 ^CNY	-0.88%		+1.62%	+13.48%

May. 06	China Grants Drug Registration Certificate to C.Q. Pharmaceutical's Anti-Inflammatory Drug	MT
Apr. 26	C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

C.Q. Pharmaceutical Holding Co., Ltd. Approves 2021 Interim Profit Distribution Plan

September 09, 2021 at 03:33 pm EDT

C.Q. Pharmaceutical Holding Co., Ltd. approved 2021 interim profit distribution plan of CNY 0.40000000 per 10 shares (tax included), at the Extraordinary General Meeting of 2021 on 08 September 2021.

Latest news about C.Q. Pharmaceutical Holding Co., Ltd.

China Grants Drug Registration Certificate to C.Q. Pharmaceutical's Anti-Inflammatory Drug	May. 06	MT
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 26	CI
C.Q. Pharma's Unit Gets Nod to Market Pregabalin Capsules	Mar. 12	MT
C.Q. Pharmaceutical Considers Potential Change in Actual Controller; Shares Jump 8%	Feb. 06	MT
C.Q. Pharmaceutical Holding Co., Ltd. Announces Executive Appointments	Dec. 01	CI
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	23-10-26	CI
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-24	CI
C.Q. Pharmaceutical Unit Buys Land-Use Rights in Chongqing For 51 Million Yuan	23-08-17	MT
C.Q. Pharmaceutical Withdraws Registration Application for Prasugrel Hydrochloride Tablets	23-07-21	MT
C.Q. Pharma Registers Hypertension Drug in China	23-07-06	MT
C.Q. Pharmaceutical Holding Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2022, Payable on 11 July 2023	23-07-05	CI
C.Q. Pharmaceutical Holding Co., Ltd. Approves Cash Dividend for 2022	23-05-19	CI
C.Q. Pharmaceutical Holding Co., Ltd. Proposes Final Cash Dividend for 2022	23-04-27	CI
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-04-26	CI
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-26	CI
C.Q. Pharmaceutical Unit Issues 300 Million Yuan Ultra-Short-Term Loan	23-02-23	MT
Fosun Pharma Signs Supply and Lease Agreements With Subsidiary	22-12-23	MT
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	22-10-26	CI
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-25	CI
C.Q. Pharmaceutical Holding Co., Ltd. Announces Implementation of 2021 Final Profit Distribution Plan, Payable on 28 June 2022	22-06-20	CI
C.Q. Pharmaceutical Holding Co., Ltd. Announces Cash Dividend for 2021	22-05-23	CI
C.Q. Pharmaceutical Holding Co., Ltd. Proposes Dividend for 2021	22-05-05	CI
C.Q. Pharmaceutical Holding Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-04-29	CI
Chongqing Pharmaceutical Co., Ltd. announced that it has received CNY 400.000004 million in funding from C.Q. Pharmaceutical Holding Co., Ltd.	22-01-06	CI
C.Q. Pharmaceutical Holding Co., Ltd. Approves Board and Executive Appointments	21-11-30	CI

Chart C.Q. Pharmaceutical Holding Co., Ltd.

Duration

Period

Chart C.Q. Pharmaceutical Holding Co., Ltd.

More charts

C.Q. Pharmaceutical Holding Co., Ltd., formerly CHONGQING JIANFENG CHEMICAL CO., LTD, is a China-based company principally engaged in the wholesale and retail business of pharmaceuticals and medical devices. The Companyâs products include chemical drugs, biopharmaceuticals, Chinese traditional patent medicines, Chinese herbal medicines, medical devices, health products and cosmetics.

Sector

Pharmaceuticals

Calendar

2024-05-17 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for C.Q. Pharmaceutical Holding Co., Ltd.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

5.64

Average target price

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
C.Q. PHARMACEUTICAL HOLDING CO., LTD.	+13.48%	1.35B
MCKESSON CORPORATION	+19.79%	72.09B
CARDINAL HEALTH, INC.	-2.74%	23.88B
SINOPHARM GROUP CO. LTD.	+10.27%	8.89B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+9.15%	8.46B
HUADONG MEDICINE CO., LTD	-17.39%	8.29B
H. LUNDBECK A/S	+8.36%	4.9B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+17.69%	4.34B
EBOS GROUP LIMITED	-3.66%	3.98B
GALENICA AG	-2.41%	3.89B

Pharmaceuticals Wholesale